🔗 Share this article Users Coming Off Slimming Injections Gain Back Pounds Four Times Faster Than Those on Conventional Diets Obesity treatment often requires long-term strategies. Fresh analysis indicates that people who come off popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end conventional lifestyle regimens. Published data in a prominent medical journal points out that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month upon discontinuation. "Users purchasing such treatments need to be aware of the potential of quick rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb. Such speed of regain implies a return to original mass in about 18 months. Weighing Treatments The study, which looked at dozens of studies involving over 9,000 of patients, compared the results of these new drugs with other pills. Researchers note that people who shed pounds through dieting generally see a more gradual creep back—perhaps 100 grams monthly—once they finish. The Reason for the Quick Rebound Nutrition scientists suggest the mechanism of the drugs is key to understanding the heightened regain. GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Sustained high doses of GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher. "Discontinuation of this hormone supplement results in hunger is no longer kept in check, making excessive eating a significant risk." A Lifelong Issue? The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications. Professionals argue that, given the high risk of weight regain, the therapy is often long-term. This perspective is reinforced by drug manufacturers, who state that the results "emphasize the long-term nature of obesity," comparing it to managing diseases like diabetes. Patient Testimonies Individuals who have come off the medication report a intense resurgence of appetite. "I experienced a trigger flipping and you're instantly ravenous," recalled a patient. This difficulty is worsened if users have not adopted sustainable lifestyle or habit modifications during treatment. Significant Use Figures suggest that millions of people in the UK have used these injections in the past year, with interest continuing to grow. Adoption is higher among women compared to men. The middle-aged age group shows the greatest usage rates. A large proportion obtain the medications through private healthcare rather than public health services. In conclusion, clinicians caution that while GLP-1 drugs are potent tools for weight loss, they are not a magic fix and maintained weight loss likely depends on combined behavioural management.
Obesity treatment often requires long-term strategies. Fresh analysis indicates that people who come off popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who end conventional lifestyle regimens. Published data in a prominent medical journal points out that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month upon discontinuation. "Users purchasing such treatments need to be aware of the potential of quick rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb. Such speed of regain implies a return to original mass in about 18 months. Weighing Treatments The study, which looked at dozens of studies involving over 9,000 of patients, compared the results of these new drugs with other pills. Researchers note that people who shed pounds through dieting generally see a more gradual creep back—perhaps 100 grams monthly—once they finish. The Reason for the Quick Rebound Nutrition scientists suggest the mechanism of the drugs is key to understanding the heightened regain. GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Sustained high doses of GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher. "Discontinuation of this hormone supplement results in hunger is no longer kept in check, making excessive eating a significant risk." A Lifelong Issue? The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications. Professionals argue that, given the high risk of weight regain, the therapy is often long-term. This perspective is reinforced by drug manufacturers, who state that the results "emphasize the long-term nature of obesity," comparing it to managing diseases like diabetes. Patient Testimonies Individuals who have come off the medication report a intense resurgence of appetite. "I experienced a trigger flipping and you're instantly ravenous," recalled a patient. This difficulty is worsened if users have not adopted sustainable lifestyle or habit modifications during treatment. Significant Use Figures suggest that millions of people in the UK have used these injections in the past year, with interest continuing to grow. Adoption is higher among women compared to men. The middle-aged age group shows the greatest usage rates. A large proportion obtain the medications through private healthcare rather than public health services. In conclusion, clinicians caution that while GLP-1 drugs are potent tools for weight loss, they are not a magic fix and maintained weight loss likely depends on combined behavioural management.